Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.120
-0.020 (-1.75%)
At close: Aug 29, 2025, 4:00 PM
1.100
-0.020 (-1.79%)
After-hours: Aug 29, 2025, 5:47 PM EDT
Boundless Bio Stock Forecast
Stock Price Forecast
The 3 analysts that cover Boundless Bio stock have a consensus rating of "Buy" and an average price target of $4.00, which forecasts a 257.14% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $5.00.
Price Target: $4.00 (+257.14%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Boundless Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 2 |
| Buy | 2 | 2 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $4 | Strong Buy | Maintains | $5 → $4 | +257.14% | Aug 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +346.43% | Jun 2, 2025 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $15 → $3 | Buy → Hold | Downgrades | $15 → $3 | +167.86% | May 28, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 13, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +2,132.14% | Apr 22, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.51
from -3.85
EPS Next Year
-2.48
from -2.51
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.05 | -1.86 | |
| Avg | -2.51 | -2.48 | |
| Low | -2.90 | -3.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.